World Pharma Newsfeed
Lilly Halts Development of Semagacestat for Alzheimer's Disease
Eli Lilly and Company (NYSE: LLY) will halt development of semagacestat, a gamma secretase inhibitor being studied as a ...
FDA Proposes Withdrawal of Low Blood Pressure Drug
The U.S. Food and Drug Administration proposed to withdraw approval of the drug midodrine hydrochloride, used to treat t...
International Society for Cellular Therapy (ISCT) launches Cell Therapy Industry Partnership
Many companies in the cell therapy regenerative medicine market including Roche, Genzyme, Athersys, Miltenyi Biotec, Hos...
Data on Electronic Sampling, Online Promotion, Tech-Enabled Reps, Customer Service, and iPads
Pharmaceutical and healthcare market research company Manhattan Research releases the tenth version of ePharma Physician...
Lundbeck reports strongly increasing profits with EBIT growth of 30%
H. Lundbeck A/S (Lundbeck) reports second quarter revenue of DKK 3,767 million. An increase of 7% compared to the second...
Abbott Launches New Psoriasisanswers.com Web site
August marks National Psoriasis Awareness Month, an opportunity to raise awareness about psoriasis, a skin disease that ...
EMA and US FDA seek potential candidate companies for joint GMP inspection programme
The European Medicines Agency (EMA) and the Food and Drug Administration of the United States of America (US FDA) contin...
Pharma Marketing 2010 - Frankfurt
30 September 2010, Frankfurt, Germany.
Pharma Marketing 2010 in Frankfurt provides a key platform for Europe's pharmaceu...
Amgen Announces Top-Line Results of Phase 3 Head and Neck Cancer Trial
Amgen (Nasdaq: AMGN) today announced top-line results from a randomized Phase 3 trial evaluating Vectibix(R) (panitumuma...
Pfizer Reports Second-Quarter 2010 Results
Pfizer Inc. (NYSE: PFE) has reported financial results for second-quarter 2010. Since the acquisition of Wyeth was compl...
